HomeCompareXVIPF vs YUM

XVIPF vs YUM: Dividend Comparison 2026

XVIPF yields 8.77% · YUM yields 1.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YUM wins by $71.3K in total portfolio value· pulled ahead in Year 6
10 years
XVIPF
XVIPF
● Live price
8.77%
Share price
$22.81
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$35.7K
Annual income
$1,524.79
Full XVIPF calculator →
YUM
YUM
● Live price
1.85%
Share price
$155.48
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.0K
Annual income
$39,957.33
Full YUM calculator →

Portfolio growth — XVIPF vs YUM

📍 YUM pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXVIPFYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XVIPF + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XVIPF pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XVIPF
Annual income on $10K today (after 15% tax)
$745.26/yr
After 10yr DRIP, annual income (after tax)
$1,296.07/yr
YUM
Annual income on $10K today (after 15% tax)
$157.45/yr
After 10yr DRIP, annual income (after tax)
$33,963.73/yr
At 15% tax rate, YUM beats the other by $32,667.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XVIPF + YUM for your $10,000?

XVIPF: 50%YUM: 50%
100% YUM50/50100% XVIPF
Portfolio after 10yr
$71.4K
Annual income
$20,741.06/yr
Blended yield
29.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

XVIPF
Analyst Ratings
1
Buy
1
Sell
Consensus: Buy
Altman Z
16.5
Piotroski
5/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+11.4% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XVIPF buys
0
YUM buys
0
No recent congressional trades found for XVIPF or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXVIPFYUM
Forward yield8.77%1.85%
Annual dividend / share$2.00$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4%
Portfolio after 10y$35.7K$107.0K
Annual income after 10y$1,524.79$39,957.33
Total dividends collected$12.0K$80.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyHold

Year-by-year: XVIPF vs YUM ($10,000, DRIP)

YearXVIPF PortfolioXVIPF Income/yrYUM PortfolioYUM Income/yrGap
1$11,577$876.78$10,980$280.44+$597.00XVIPF
2$13,336$948.62$12,185$435.72+$1.2KXVIPF
3$15,291$1,021.27$13,722$684.14+$1.6KXVIPF
4$17,455$1,094.36$15,773$1,090.14+$1.7KXVIPF
5$19,845$1,167.56$18,650$1,773.02+$1.2KXVIPF
6← crossover$22,474$1,240.55$22,921$2,966.37$447.00YUM
7$25,361$1,313.03$29,685$5,158.69$4.3KYUM
8$28,521$1,384.72$41,216$9,453.02$12.7KYUM
9$31,972$1,455.38$62,672$18,571.31$30.7KYUM
10$35,735$1,524.79$107,016$39,957.33$71.3KYUM

XVIPF vs YUM: Complete Analysis 2026

XVIPFStock

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.

Full XVIPF Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this XVIPF vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XVIPF vs SCHDXVIPF vs JEPIXVIPF vs OXVIPF vs KOXVIPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.